Profile
Ehud Shoshani served as the Chief Executive Officer at Quintiles UK Ltd.
and as the Medical Director at OMRIX Biopharmaceuticals, Inc. and Gamida Cell Ltd.
He also worked as the Vice President-Clinical Affairs at Aevi Genomic Medicine, Inc. Shoshani holds a doctorate degree from Technion-Israel Institute of Technology, which he received in 1978.
Former positions of Ehud Shoshani
Companies | Position | End |
---|---|---|
GAMIDA CELL LTD. | Chief Tech/Sci/R&D Officer | - |
Quintiles UK Ltd. | President | - |
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Chief Tech/Sci/R&D Officer | - |
AEVI GENOMIC MEDICINE, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Ehud Shoshani
Technion-Israel Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
GAMIDA CELL LTD. | Health Technology |
Private companies | 3 |
---|---|
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
Quintiles UK Ltd. | |
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
- Stock Market
- Insiders
- Ehud Shoshani